1995
DOI: 10.1093/ndt/10.9.1662
|View full text |Cite
|
Sign up to set email alerts
|

Expression of receptors for advanced glycosylated end-products in renal disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1997
1997
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 23 publications
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…RAGE is upregulated wherever its ligands accumulate, and ligand binding with RAGE results in rapid and sustained cellular activation and gene transcription [14,16,17]. Its involvement in inflammation has been suggested by many studies, and it is upregulated in most inflammatory lesions studied to date [17][18][19][20][21][22][23][24][25]. Soluble RAGE (sRAGE), which is a truncated form of the receptor spanning the extracellular ligand-binding domain, and endogenous secreted RAGE (esRAGE) generated by alternative splicing, competes with full-length RAGE for ligand binding.…”
Section: Introductionmentioning
confidence: 99%
“…RAGE is upregulated wherever its ligands accumulate, and ligand binding with RAGE results in rapid and sustained cellular activation and gene transcription [14,16,17]. Its involvement in inflammation has been suggested by many studies, and it is upregulated in most inflammatory lesions studied to date [17][18][19][20][21][22][23][24][25]. Soluble RAGE (sRAGE), which is a truncated form of the receptor spanning the extracellular ligand-binding domain, and endogenous secreted RAGE (esRAGE) generated by alternative splicing, competes with full-length RAGE for ligand binding.…”
Section: Introductionmentioning
confidence: 99%